HIV pre-exposure prophylaxis (PrEP) is a prevention strategy which includes the regular or event-driven use of antiretroviral medication to prevent HIV infection in adults. Several clinical trials ...

Please provide your email address to receive an email when new articles are posted on . Those living in Black or Hispanic neighborhoods or who were on Medicaid had lower proportions of new PrEP use.

Real-world data show DoxyPEP implementation among PrEP users significantly reduces the incidence of chlamydia and syphilis.

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

HIV pre-exposure prophylaxis (PrEP) is an effective and safe intervention for individuals with behaviors that are considered high risk for acquiring HIV infection. Despite the success of this ...

MONTRÉAL, March 25, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (PFE) and Shionogi as shareholders, is pleased to ...

ARLINGTON, Virginia, June 11-- The HIV Medicine Association issued the following statement by Chair W. David Hardy on the U.S. Preventive Services Task Force's final pre-exposure prophylaxis ...

HIV medication Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) will be offered free by the end of January, Prime Minister Robert Abela said on Sunday. NGOs and people living ...